Information related to the use of bilastine in pregnancy is limited. For the safety, avoid using in pregnant women.
It is not known if bilastine is excreted in breastmilk.
The decision to continue or discontinue breastfeeding during therapy should take into account the risk of infant exposure, the benefits of breastfeeding to the infant, and benefits of treatment to the mother.
Sign Out